Amgen Inc (AMGN)

Featured here, the Income Statement (earnings report) for Amgen Inc, showing the company's financial performance from operating and non operating activities such as revenue, expenses and income for the last 4 periods (either quarterly or annually).

3,920.00 +0.00 (+0.00%)

01/06 Closed MXN Disclaimer

AMGN Income Statement

Total Revenue
Total Operating Expenses
Operating Income

Name	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022
Total Revenue	6,105	6,839	6,652	6,594	6,238
Revenue	5,846	6,552	6,237	6,281	5,731
Other Revenue, Total	259	287	415	313	507
Cost of Revenue, Total	1,720	1,747	1,588	1,510	1,561
Gross Profit	4,385	5,092	5,064	5,084	4,677
Total Operating Expenses	4,038	4,636	3,987	4,418	3,738
Selling/General/Admin. Expenses, Total	1,258	1,572	1,287	1,327	1,228
Research & Development	1,058	1,324	1,112	1,039	959
Depreciation / Amortization	207	-450	237	165	204
Interest Expense (Income) - Net Operating	-543	-415	-368	-328	-295
Unusual Expense (Income)	-	-	-	-	-
Other Operating Expenses, Total	338	858	131	705	81
Operating Income	2,067	2,203	2,665	2,176	2,500
Interest Income (Expense), Net Non-Operating	-	-	-	-	-
Gain (Loss) on Sale of Assets	-47	-426	192	-39	-50
Other, Net	-1,328	881	81	684	875
Net Income Before Taxes	3,442	1,748	2,392	1,531	1,675
Provision for Income Taxes	601	132	249	214	199
Net Income After Taxes	2,841	1,616	2,143	1,317	1,476
Minority Interest	-	-	-	-	-
Equity In Affiliates	-	-	-	-	-
U.S GAAP Adjustment	-	-	-	-	-
Net Income Before Extraordinary Items	2,841	1,616	2,143	1,317	1,476
Total Extraordinary Items	0	0	0	0	0
Net Income	2,841	1,616	2,143	1,317	1,476
Total Adjustments to Net Income	0	0	0	0	0
Income Available to Common Excluding Extraordinary Items	2,841	1,616	2,143	1,317	1,476
Dilution Adjustment	0.36	2.11	1.76	1.35	-0.68
Diluted Net Income	2,840.64	1,613.89	2,141.24	1,315.65	1,476.68
Diluted Weighted Average Shares	538	539	538	537	551
Diluted EPS Excluding Extraordinary Items	5.28	2.99	3.98	2.45	2.68
DPS - Common Stock Primary Issue	2.13	1.94	1.94	1.94	1.94
Diluted Normalized EPS	4.09	2.47	2.47	1.83	1.96

* In Millions of (except for per share items)

Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.